Literature DB >> 21350861

Reversal of neuromuscular blockade with sugammadex in an obese myasthenic patient undergoing thymectomy.

Helena Argiriadou, Kyriakos Anastasiadis, Evanthia Thomaidou, Dimitrios Vasilakos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21350861     DOI： 10.1007/s00540-011-1101-z

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  3 in total

1.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.

Authors:  Anton Bom; Mark Bradley; Ken Cameron; John K Clark; Jan Van Egmond; Helen Feilden; Elizabeth J MacLean; Alan W Muir; Ronald Palin; David C Rees; Ming-Qiang Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2002-01-18       Impact factor: 15.336

Review 2.  [Anesthesia in patients with myasthenia gravis].

Authors:  M Blobner; R Mann
Journal:  Anaesthesist       Date:  2001-07       Impact factor: 1.041

3.  The use of sugammadex in a patient with myasthenia gravis.

Authors:  C Unterbuchner; H Fink; M Blobner
Journal:  Anaesthesia       Date:  2010-01-23       Impact factor: 6.955
  3 in total
  5 in total

1.  The effect of rocuronium, sugammadex, and their combination on cardiac muscle and diaphragmatic skeletal muscle cells.

Authors:  Yildiray Kalkan; Habib Bostan; Levent Tumkaya; Yakup Tomak; Mehmet Bostan; Adnan Yilmaz; Hasan Turut; Ahmet Temiz; Alper Yalçin; Alparslan Turan
Journal:  J Anesth       Date:  2012-07-14       Impact factor: 2.078

2.  Sensitivity to rocuronium-induced neuromuscular block and reversibility with sugammadex in a patient with myotonic dystrophy.

Authors:  Akihiro Kashiwai; Takahiro Suzuki; Setsuro Ogawa
Journal:  Case Rep Anesthesiol       Date:  2012-04-09

Review 3.  Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature.

Authors:  Hermann Dos Santos Fernandes; Jorge Luiz Saraiva Ximenes; Daniel Ibanhes Nunes; Hazem Adel Ashmawi; Joaquim Edson Vieira
Journal:  BMC Anesthesiol       Date:  2019-08-17       Impact factor: 2.217

4.  Myasthenia gravis and sugammadex: A case report and review of the literature.

Authors:  Sujana Dontukurthy; Carrie Wisler; Vidya Raman; Joseph D Tobias
Journal:  Saudi J Anaesth       Date:  2020-03-05

5.  Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases.

Authors:  Tomas Vymazal; Martina Krecmerova; Vladimír Bicek; Robert Lischke
Journal:  Ther Clin Risk Manag       Date:  2015-10-15       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.